Please find attached the first half 2024 financial report including the Responsibility Statement.
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
[email protected]
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
- Vistin Pharma ASA Q2 report 2024
